414 filings
Page 11 of 21
UPLOAD
vtpuemy7xpqv00mfocy7
22 Apr 21
Letter from SEC
12:00am
F-1
wzr8139c7lve
21 Apr 21
Registration statement (foreign)
4:17pm
EFFECT
taqo6zmvb33kaqmw4lw
2 Apr 21
Notice of effectiveness
12:16am
EFFECT
u1w kv15uijykl8igf
2 Apr 21
Notice of effectiveness
12:16am
POS AM
5cx t4ertcx
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
POS AM
iz5y1piq lvgx5nndw
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
6-K
eecd 1x17i6umhsc4o
9 Mar 21
Report of Foreign Private Issuer
4:10pm
D
rjr95
9 Mar 21
$3.87M in equity / options, 18 investors
12:00am
6-K
35067fs rsq
2 Mar 21
Current report (foreign)
4:07pm
6-K
xcfw5xky4hdfq1d 6p1x
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
nys3kg0qoqaim 304
1 Mar 21
Current report (foreign)
4:00pm
6-K
xn2wq1i x118vhu
24 Feb 21
SciSparc Corporate Presentation February 2021
9:27am
6-K
3k5q95 tjm6
17 Feb 21
Report of Foreign Private Issuer
8:35am
6-K
wnppzjp8 04hvz3n7
11 Feb 21
SciSparc Announces Rebranding and Business Updates
10:01am
6-K
q6si1ep1s5g 3k
10 Feb 21
SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate
8:33am
6-K
f034ktx40ncfplv1i4f
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmide™ Pills
8:36am
424B3
h0nyhbfpvm
3 Feb 21
Prospectus supplement
12:10pm
6-K
brrt p7cwpczxd5
28 Jan 21
Report of Foreign Private Issuer
9:36am
6-K
1hnnc6z3
25 Jan 21
Special General Meeting of Shareholders
5:27pm